All Stories

  1. Evaluating contributions of mometasone (MF), indacaterol (IND) and glycopyrronium (GLY) to reduction of exacerbations in patients with inadequately controlled asthma: Results from the IRIDIUM study

    Article • September 2021, European Respiratory Society (ERS)

    Kenneth Chapman

  2. Reduction in asthma exacerbations with indacaterol/glycopyrronium/mometasone high-dose versus medium-dose: a post hoc analysis from the IRIDIUM study

    Article • September 2020, European Respiratory Society (ERS)

    Kenneth Chapman

  3. Treatment of Asthma with Breezhaler

    Article • September 2019, European Respiratory Society (ERS)

    Kenneth Chapman, Professor Kenneth R Chapman

  4. Indacaterol/glycopyrronium/mometasone furoate combination consistently shows lung function benefits in patients with asthma

    Article • September 2019, European Respiratory Society (ERS)

    Kenneth Chapman

  5. Usability of mepolizumab single-use prefilled autoinjector for patient self-administration

    Article • Journal of Asthma, June 2019, Taylor & Francis

    Kenneth Chapman

  6. The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis

    Article • International Journal of Chronic Obstructive Pulmonary Disease, August 2016, Dove Medical Press

    Dr Marc Miravitlles, Kenneth Chapman

  7. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial

    Article • The Lancet, July 2015, Elsevier

    Kenneth Chapman